Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $7.08 billion. The enterprise value is $5.62 billion.
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 82.26 million shares outstanding. The number of shares has increased by 14.80% in one year.
| Current Share Class | 82.26M |
| Shares Outstanding | 82.26M |
| Shares Change (YoY) | +14.80% |
| Shares Change (QoQ) | +8.47% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 82.25% |
| Float | 55.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 137.55 |
| Forward PS | 105.97 |
| PB Ratio | 4.59 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 109.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.81 |
| Quick Ratio | 10.39 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -989.62 |
Financial Efficiency
Return on equity (ROE) is -27.09% and return on invested capital (ROIC) is -17.82%.
| Return on Equity (ROE) | -27.09% |
| Return on Assets (ROA) | -17.16% |
| Return on Invested Capital (ROIC) | -17.82% |
| Return on Capital Employed (ROCE) | -22.12% |
| Weighted Average Cost of Capital (WACC) | 15.40% |
| Revenue Per Employee | $203,462 |
| Profits Per Employee | -$1.25M |
| Employee Count | 253 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +195.71% in the last 52 weeks. The beta is 2.06, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +195.71% |
| 50-Day Moving Average | 83.84 |
| 200-Day Moving Average | 68.16 |
| Relative Strength Index (RSI) | 53.47 |
| Average Volume (20 Days) | 512,937 |
Short Selling Information
The latest short interest is 9.62 million, so 11.70% of the outstanding shares have been sold short.
| Short Interest | 9.62M |
| Short Previous Month | 10.40M |
| Short % of Shares Out | 11.70% |
| Short % of Float | 17.48% |
| Short Ratio (days to cover) | 15.46 |
Income Statement
In the last 12 months, KYMR had revenue of $51.48 million and -$315.00 million in losses. Loss per share was -$3.55.
| Revenue | 51.48M |
| Gross Profit | -283.00M |
| Operating Income | -355.27M |
| Pretax Income | -315.00M |
| Net Income | -315.00M |
| EBITDA | -348.59M |
| EBIT | -355.27M |
| Loss Per Share | -$3.55 |
Full Income StatementBalance Sheet
The company has $650.93 million in cash and $80.47 million in debt, with a net cash position of $1.47 billion or $17.81 per share.
| Cash & Cash Equivalents | 650.93M |
| Total Debt | 80.47M |
| Net Cash | 1.47B |
| Net Cash Per Share | $17.81 |
| Equity (Book Value) | 1.54B |
| Book Value Per Share | 18.73 |
| Working Capital | 614.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$242.58 million and capital expenditures -$1.42 million, giving a free cash flow of -$244.00 million.
| Operating Cash Flow | -242.58M |
| Capital Expenditures | -1.42M |
| Depreciation & Amortization | 6.69M |
| Net Borrowing | -1.64M |
| Free Cash Flow | -244.00M |
| FCF Per Share | -$2.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -690.17% |
| Pretax Margin | -611.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.80% |
| Shareholder Yield | -14.80% |
| Earnings Yield | -4.45% |
| FCF Yield | -3.45% |
Analyst Forecast
The average price target for KYMR is $107.65, which is 25.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $107.65 |
| Price Target Difference | 25.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (5Y) | 88.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 18.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 18.29 |
| Piotroski F-Score | 2 |
